Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Annals of the New York Academy of Sciences
|
May 2, 2008
Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines
Alin Stirban, Monica Negrean, Christian Götting, et al.
Circulation
|
July 16, 2003
Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries
LiFeng Zhang, Andrew Zalewski, Yuchuan Liu, et al.
Plos One
|
February 11, 2015
Chronic ingestion of advanced glycation end products induces degenerative spinal changes and hypertrophy in aging pre-diabetic mice
Svenja Illien-Jünger, Young Lu, Sheeraz A Qureshi, et al.
Diabetes
|
June 28, 2002
Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse
Susanna M Hofmann, Heng-Jiang Dong, Zhu Li, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 3, 2011
Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice
Jin Wu, Tian-jun Guan, Shirong Zheng, et al.
Atherosclerosis
|
June 8, 2002
Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice
Reigh-Yi Lin, Ernane D Reis, Anthony T Dore, et al.
The American Journal of Pathology
|
July 4, 2006
Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme
Huixian Liu, Feng Zheng, Zhu Li, et al.
Mechanisms of Ageing and Development
|
July 19, 2014
Dietary advanced glycation end products are associated with decline in memory in young elderly
Rebecca K West, Erin Moshier, Irit Lubitz, et al.
Plos One
|
September 26, 2018
Pharmacologic control of oxidative stress and inflammation determines whether diabetic glomerulosclerosis progresses or decreases: A pilot study in sclerosis-prone mice
Fabrizio Grosjean, Elena M Yubero-Serrano, Feng Zheng, et al.
Circulation
|
May 8, 2002
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes
Robert H Eckel, Momtaz Wassef, Alan Chait, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Annals of the New York Academy of Sciences
|
May 2, 2008
Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines
Alin Stirban, Monica Negrean, Christian Götting, et al.
Circulation
|
July 16, 2003
Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries
LiFeng Zhang, Andrew Zalewski, Yuchuan Liu, et al.
Plos One
|
February 11, 2015
Chronic ingestion of advanced glycation end products induces degenerative spinal changes and hypertrophy in aging pre-diabetic mice
Svenja Illien-Jünger, Young Lu, Sheeraz A Qureshi, et al.
Diabetes
|
June 28, 2002
Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse
Susanna M Hofmann, Heng-Jiang Dong, Zhu Li, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 3, 2011
Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice
Jin Wu, Tian-jun Guan, Shirong Zheng, et al.
Atherosclerosis
|
June 8, 2002
Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice
Reigh-Yi Lin, Ernane D Reis, Anthony T Dore, et al.
The American Journal of Pathology
|
July 4, 2006
Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme
Huixian Liu, Feng Zheng, Zhu Li, et al.
Mechanisms of Ageing and Development
|
July 19, 2014
Dietary advanced glycation end products are associated with decline in memory in young elderly
Rebecca K West, Erin Moshier, Irit Lubitz, et al.
Plos One
|
September 26, 2018
Pharmacologic control of oxidative stress and inflammation determines whether diabetic glomerulosclerosis progresses or decreases: A pilot study in sclerosis-prone mice
Fabrizio Grosjean, Elena M Yubero-Serrano, Feng Zheng, et al.
Circulation
|
May 8, 2002
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes
Robert H Eckel, Momtaz Wassef, Alan Chait, et al.
Page
of 9